Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07490314 · ClinicalTrials.gov registry record
Blood Product Supply
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 100
- Enrollment target
NCT07490314 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 100 participants.
The verdict
NCT07490314 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Data about the links between Coronavirus disease 2019(COVID-19) and the safety of blood products during the pandemic is inadequate. During the COVID-19 pandemic, high volumes of patients receiving blood products due to post-terminal surgical complications depleted stores for the entire hospital, resulting in surgeons unable to acquire emergent blood products. Data from this study can be used to develop a policy on how to handle blood shortage issues during this and future pandemics. Also, this data can be used to determine future policies on use of blood products from COVID-19-positive donors.
Interventions
- OTHER Document delays and frequencies of inadequate blood products for emergent cases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2025-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07490314
The ClinicalTrials.gov registry entry for NCT07490314 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Document delays and frequencies of inadequate blood products for emergent cases is the first listed.
NCT07490314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07490314 about?
NCT07490314 is a clinical study titled "Blood Product Supply". Data about the links between Coronavirus disease 2019(COVID-19) and the safety of blood products during the pandemic is inadequate. During the COVID-19 pandemic, high volumes of patients receiving blood products due to post-terminal surgical complications depleted stores for the entire hospital, res...
What is the current status of trial NCT07490314?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-03-01. Estimated completion is 2025-06-25.
What interventions are being tested in trial NCT07490314?
The interventions under investigation include: Document delays and frequencies of inadequate blood products for emergent cases (OTHER).
Who is sponsoring clinical trial NCT07490314?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.